Nexeon MedSystems Inc. (NXNN)

0.0001 0.0000 (0.00%) At close: 10:06AM EDT

Nexeon MedSystems Inc.

1910 Pacific Avenue
Suite 20000
Dallas, TX 75201
United States
844-919-9990
https://www.nexeonmedsystems.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 62

Key executives

Name	Title	Pay	Exercised	Year born
Mr. William Rosellini J.D., M.B.A., M.S.	Chairman & CEO	2	N/A	1980
Mr. Christopher R. Miller	Chief Financial Officer	131.75k	N/A	1970
Mr. Cathal Mc Fadden	Vice President of Operations	N/A	N/A	N/A
Dr. Austin Duke Ph.D.	Chief Science Officer	N/A	N/A	N/A

Amounts are as of 31 December 2017, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Corporate governance

Nexeon MedSystems Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.